Himachal Pradesh gets first installment of Rs 225 crore for Bulk Drug Park
He said that bid process management has also been initiated for selection of consultants for the Environmental Clearance of the Bulk Drug Park.;
Himachal Pradesh: The Himachal Pradesh government has received the first installment of grant-in-aid of Rs 225 crore from the Department of Pharmaceuticals, Government of India (GoI) for the development of Common Infrastructure Facilities for the Bulk Drug Park in Una.
Chief Minister, Thakur Sukhvinder Singh Sukhu, while expressing his pleasure on the formation of the State Implementing Agency (SIA) and release of first installment of Rs. 225 crore said that “Bulk Drug Park is a project of national importance and crucial for strengthening the States’ existing pharma ecosystem. This grant-in-aid was given under the scheme guidelines “Promotion of Bulk Drug Park” Scheme notified by the Department of Pharmaceuticals (DoP), Ministry of Chemical and Fertilizer, Government of India (GoI) in 2020.
He further said that keeping in mind the investment potential of around Rs. 8000-10,000 crore and expected employment opportunities for more than 15,000 persons, the State Government would ensure timely execution of this mega Project. He said that the Government has registered the SIA “Himachal Pradesh Bulk Drug Park Infrastructure Limited (HPBDPIL)” with the Ministry of Corporate Affairs on 15th February, 2023.
Read also: Himachal Pradesh: PM Modi lays foundation stone of Una Bulk Drug Park
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.